Search

everythinglearnresearchcommunity

for

Search:↓

New biomarkers and potential treatments for skin diseases were identified.

Confocal Laser Scanning Microscopy (CLSM) is a useful tool for studying how drugs interact with skin and diagnosing skin disorders, despite some limitations.

COVID-19 can worsen autoimmune skin diseases and increase their occurrence.

Imbalanced skin microbiome can worsen skin conditions like acne and eczema.

IBS is linked to certain skin conditions like psoriasis and rosacea, and vice versa.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Improving diet and lifestyle can help manage skin conditions linked to insulin resistance and inflammation.

Depression and skin autoimmune diseases are linked, needing combined care for better treatment.

Organic and biogenic nanocarriers can improve drug delivery but face challenges like consistency and safety.

Hypothyroidism may cause certain types of hair loss.

New treatments focusing on immune pathways show promise for stubborn hair loss.

miRNA-based therapies show promise for treating skin diseases, including hair loss, in animals.

Peimine helps heal skin wounds by activating a specific cell signaling pathway.

The research suggests that immune cells and a specific type of cell death called ferroptosis are involved in Frontal fibrosis alopecia.

Higher LDL cholesterol may increase the risk of hair loss, while HDL cholesterol does not.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

The protein p53 directly reduces the production of Keratin 17, a skin and hair protein, in rats with radiation dermatitis.

Further research is needed to understand how the microbiome affects hair loss in Alopecia Areata.

Acne involves increased lipid production and inflammation, affecting skin cell behavior and treatment resistance.

JAK inhibitors are effective for hair regrowth in severe alopecia areata.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Microneedling, especially with halometasone, improves hair regrowth and gut health in alopecia areata.

Biomimetic nanovesicles can speed up diabetic wound healing by regulating immune cell behavior and metabolism.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

PN hydrates skin; PDRN heals and regenerates skin and hair.

Janus kinase inhibitors are promising for treating scarring alopecia, but more research is needed for safety and personalized treatments.

3D spheroid culture makes stem cells better at reducing inflammation.